ICD-10-CM Code D61.1

Valid for Submission

D61.1 is a billable code used to specify a medical diagnosis of drug-induced aplastic anemia. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code D61.1 might also be used to specify conditions or terms like aplastic anemia caused by antineoplastic agent, aplastic anemia due to drugs, aplastic anemia due to drugs, drug-induced hypoplasia of bone marrow, pancytopenia caused by medication, pancytopenia due to antineoplastic chemotherapy, etc

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D61.1:

Use Additional Code

Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.

• code for adverse effect, if applicable, to identify drug T36 T50

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D61.1 are found in the index:

• - Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) - D64.9
  • - aplastic - D61.9
    • - drug-induced - D61.1
    • - due to
      • - drugs - D61.1

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Aplastic anemia caused by antineoplastic agent
• Aplastic anemia due to drugs
• Aplastic anemia due to drugs
• Drug-induced hypoplasia of bone marrow
• Pancytopenia caused by medication
• Pancytopenia due to antineoplastic chemotherapy
• Secondary aplastic anemia
• Secondary aplastic anemia

Diagnostic Related Groups

The ICD-10 code D61.1 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2020.

• 808 - MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC
• 809 - MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC
• 810 - MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC

Convert D61.1 to ICD-9

• 284.89 - Aplastic anemias NEC (Approximate Flag)

Code Classification

• Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)
  • Aplastic and other anemias and other bone marrow failure syndromes (D60-D64)
    • Oth aplastic anemias and other bone marrow failure syndromes (D61)

Code History

• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
  (First year ICD-10-CM implemented into the HIPAA code set)
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Tools

• Copy Code
• Copy Description
• View Related Codes
• Convert D61.1 to ICD-9